Illumina Inc. (ILMN) Social Stream

Illumina Inc. (ILMN): $120.25

2.82 (+2.40%)

POWR Rating

Component Grades








Add ILMN to Watchlist
Sign Up

Industry: Biotech




#26 of 362

in industry

Featured Post From StockTwits About ILMN

(Phase 3 DU Trial results Sept 9th) ATNF management team has one of best track records in the biotech world.... which can rival (or beat) that of any Large Cap Bio ( ABBV licensed their patents for Use in Humira the current #1 best selling drug).
The ATNF team is responsible for (among many other things) discovering, completing the first successful trial & approval (Remicade- the 4th all time best selling drug in the world- with over $90B total sales).
The Anti-TNF drugs were 40% of top 10 US drugs Sales in 2020 (#1, #3, #10 on the list below).
Now they have formed ATNF to gain approval for anti-TNF treatment of Fibrosis conditions with Unmet needs.. then to gain approval of the next top selling class of drug to replace the current anti-TNF Biologics, to treat arthritic & autoimmune diseases- with much fewer side effects and risk factors (class projected to be $150B by 2025).
..very undervalued ($250M) & likely about to move up considerably.
SCNC, published August 16, 2021

What Else are ILMN Traders Talking About?

Other tickers frequently mentioned alongside ILMN are ATNF and OCGN.

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!